Antiplatelet activity of benzylisoquinoline derivatives oxidized by cerium(IV) ammonium nitrate

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 16, 2003, Pages 2789-2793

  Kuo, Reen Yen ^a   Chang, Fang Rong ^a   Wu, Chin Chun ^a   Patnam, Ramesh ^a   Wang, Wei Ya ^a   Du, Ying Chi ^a   Wu, Yang Chang ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMMONIUM NITRATE; ANTITHROMBOCYTIC AGENT; BENZYLISOQUINOLINE DERIVATIVE; CERIUM; THROMBOCYTE ACTIVATING FACTOR;

ANTICOAGULATION; ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; OXIDATION; QUANTUM YIELD; THROMBOCYTE AGGREGATION;

EID: 0038107567     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00477-3     Document Type: Article

References (13)

1. D'Ocon P., Blasco R., Candenas L., Ivorra D., Lopez S., Villaverde C., Castedo L., Cortes D. Eur. J. Pharmacol. 196:1991;183.
2. Costall B., Naylor R.J. J. Med. Chem. 20:1977;190.
3. Chen K.S., Ko F.N., Teng C.M., Wu Y.C. J. Nat. Prod. 59:1996;531.
4. Kuo R.Y., Wu C.C., Chang F.R., Yeh J.L., Chen I.J., Wu Y.C. Bioorg. Med. Chem. Lett. 13:2003;821.
5. Andreu I., Cabedo N., Atassi G., Pierre A., Caignard D.H., Renard P., Cortesa D., Bermejoa A. Tetrahedron Lett. 43:2002;757.
6. (a) Hufford C.D., Sharma A.S., Oguntimein B.O. J. Pharm. Sci. 69:1980;1180. (b) McMahon R.M., Thornber C.W., Ruchirawat S. J. Chem. Soc., Perkin Trans. 1. 1982;2163.
7. (a) Hufford C.D., Sharma A.S., Oguntimein B.O. J. Pharm. Sci. 69:1980;1180. (b) McMahon R.M., Thornber C.W., Ruchirawat S. J. Chem. Soc., Perkin Trans. 1. 1982;2163.
8. (a) Isobe K., Mohri K., Takeda N., Suzuki K., Hosoi S., Tsuda Y. Chem. Pharm. Bull. 42:1994;197. (b) Isobe K., Takeda N., Mohri K., Tsuda Y. Chem. Pharm. Bull. 37:1989;3390.
9. (a) Isobe K., Mohri K., Takeda N., Suzuki K., Hosoi S., Tsuda Y. Chem. Pharm. Bull. 42:1994;197. (b) Isobe K., Takeda N., Mohri K., Tsuda Y. Chem. Pharm. Bull. 37:1989;3390.
10. (a) Maity G., Roy S.C. Synth. Commun. 23:1993;1667. (b) Stefane B., Kocevar M., Polanc S. Tetrahedron Lett. 40:1999;4429.
11. (a) Maity G., Roy S.C. Synth. Commun. 23:1993;1667. (b) Stefane B., Kocevar M., Polanc S. Tetrahedron Lett. 40:1999;4429.
12. General experimental procedure for the synthesis of compounds 1a-9a, 1b-9b, 1c-9c, and 9d. see Abstract
13. Antiplatelet aggregation assays: see: Chen K.S., Ko F.N., Teng C.M., Wu Y.C. Planta Med. 62:1996;133.